{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:17:42Z","timestamp":1790612262578,"version":"4.1.0"},"reference-count":77,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Familial hypercholesterolemia (FH) confers a greatly increased risk for premature cardiovascular disease, but remains very underdiagnosed and undertreated in primary care populations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We assessed whether using a hybrid model consisting of 2 existing FH diagnostic criteria coupled with electronic medical record (EMR) data would accurately identify patients with FH in a Midwest US metropolitan healthcare system.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective, records-based, cross-sectional study using datasets from unique EMRs of living patients. Using Structured Query Language to identify components of 2 currently approved FH diagnostic criteria, we created a hybrid model to identify individuals with FH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 264 264 records analyzed, between 794 and 1571 patients were identified as having FH based on the hybrid diagnostic model, with a prevalence of 1:300 to 1:160. These patients had a higher prevalence of premature coronary artery disease (CAD) (38-58%) than the general population (1.8%) and higher than those having a high CAD risk but no FH (10%). Although most patients were receiving lipid-lowering therapies (LLTs), only 50% were receiving guideline-recommended high-intensity LLT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Using the hybrid model, we identified FH with a higher clinical and genetic detection rate than using standard diagnostic criteria individually. Statin and other LLT use were suboptimal and below guideline recommendations. Because FH underdiagnosis and undertreatment are due partially to the challenges of implementing existing diagnostic criteria in a primary care setting, this hybrid model potentially can improve FH diagnosis and subsequent early access to appropriate treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab873","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T20:58:12Z","timestamp":1638824292000},"page":"1078-1090","source":"Crossref","is-referenced-by-count":9,"title":["Improving Familial Hypercholesterolemia Diagnosis Using an EMR-based Hybrid Diagnostic Model"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9315-6746","authenticated-orcid":false,"given":"Wael E","family":"Eid","sequence":"first","affiliation":[{"name":"St. Elizabeth Physicians Regional Diabetes Center, Covington, KY 41011, USA"},{"name":"College of Medicine, University of Kentucky, Lexington, KY 41011, USA"},{"name":"Sanford School of Medicine, University of South Dakota, Sioux Falls, SD 41011, USA"},{"name":"Faculty of Medicine, Department of Internal Medicine, Endocrine Unit, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6311-963X","authenticated-orcid":false,"given":"Emma Hatfield","family":"Sapp","sequence":"additional","affiliation":[{"name":"St. Elizabeth Healthcare, Edgewood, KY 41017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0812-3035","authenticated-orcid":false,"given":"Abby","family":"Wendt","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, Northern Kentucky University, Highland Heights, KY 41099, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8827-0475","authenticated-orcid":false,"given":"Amity","family":"Lumpp","sequence":"additional","affiliation":[{"name":"St. Elizabeth Healthcare, Edgewood, KY 41017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-9684","authenticated-orcid":false,"given":"Carl","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, Northern Kentucky University, Highland Heights, KY 41099, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"issue":"2","key":"2022032516105108900_CIT0001","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3949\/ccjm.87a.19021","article-title":"Familial hypercholesterolemia: detect, treat, and ask about family","volume":"87","author":"Shah","year":"2020","journal-title":"Cleve Clin J Med."},{"key":"2022032516105108900_CIT0002","doi-asserted-by":"crossref","first-page":"17093","DOI":"10.1038\/nrdp.2017.93","article-title":"Familial hypercholesterolaemia","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"4","key":"2022032516105108900_CIT0003","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOL.0000000000000300","article-title":"A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries","volume":"27","author":"Mundal","year":"2016","journal-title":"Curr Opin Lipidol."},{"issue":"8","key":"2022032516105108900_CIT0004","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/S2589-7500(19)30161-X","article-title":"A roadmap for familial hypercholesterolaemia control","volume":"1","author":"Pereira","year":"2019","journal-title":"Lancet Digit Health."},{"issue":"8","key":"2022032516105108900_CIT0005","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2589-7500(19)30150-5","article-title":"Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data","volume":"1","author":"Myers","year":"2019","journal-title":"Lancet Digit Health."},{"issue":"5","key":"2022032516105108900_CIT0006","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacl.2016.07.011","article-title":"US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry","volume":"10","author":"Ahmad","year":"2016","journal-title":"J Clin Lipidol."},{"issue":"22","key":"2022032516105108900_CIT0007","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The Agenda for Familial Hypercholesterolemia: a Scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation."},{"issue":"1","key":"2022032516105108900_CIT0008","doi-asserted-by":"crossref","first-page":"bvaa122","DOI":"10.1210\/jendso\/bvaa122","article-title":"Management of familial hypercholesterolemia: current status and future perspectives","volume":"5","author":"Lui","year":"2021","journal-title":"J Endocr Soc."},{"issue":"22","key":"2022032516105108900_CIT0009","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.120.046961","article-title":"What is familial hypercholesterolemia, and why does it matter?","volume":"141","author":"Khera","year":"2020","journal-title":"Circulation."},{"issue":"45","key":"2022032516105108900_CIT0010","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J."},{"issue":"12","key":"2022032516105108900_CIT0011","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","article-title":"Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events","volume":"6","author":"Zhang","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"6","key":"2022032516105108900_CIT0012","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J Intern Med."},{"issue":"4","key":"2022032516105108900_CIT0013","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MOL.0b013e3283556c33","article-title":"Identification of people with heterozygous familial hypercholesterolemia","volume":"23","author":"Haase","year":"2012","journal-title":"Curr Opin Lipidol."},{"key":"2022032516105108900_CIT0014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2018.04.037","article-title":"Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study","volume":"274","author":"Weng","year":"2018","journal-title":"Atherosclerosis."},{"issue":"15","key":"2022032516105108900_CIT0015","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/heartjnl-2020-318813","article-title":"Improving detection and management of familial hypercholesterolaemia in Australian general practice","volume":"107","author":"Brett","year":"2021","journal-title":"Heart"},{"issue":"24","key":"2022032516105108900_CIT0016","doi-asserted-by":"crossref","first-page":"e013225","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"2022032516105108900_CIT0017","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.amjcard.2020.07.008","article-title":"Prevalence and characteristics of patients with primary severe hypercholesterolemia in a multidisciplinary healthcare system","volume":"132","author":"Eid","year":"2020","journal-title":"Am J Cardiol."},{"issue":"11","key":"2022032516105108900_CIT0018","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"2022032516105108900_CIT0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2020.07.022","article-title":"Electronic health records to facilitate continuous detection of familial hypercholesterolemia","volume":"310","author":"Pepplinkhuizen","year":"2020","journal-title":"Atherosclerosis."},{"issue":"11","key":"2022032516105108900_CIT0020","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)","volume":"133","author":"de Ferranti","year":"2016","journal-title":"Circulation."},{"key":"2022032516105108900_CIT0021","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2296-4-18","article-title":"Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials","volume":"4","author":"Edwards","year":"2003","journal-title":"BMC Fam Pract."},{"issue":"21","key":"2022032516105108900_CIT0022","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.117.032321","article-title":"Prevalence and predictors of cholesterol screening, awareness, and statin treatment among us adults with familial hypercholesterolemia or other forms of severe dyslipidemia (1999-2014)","volume":"137","author":"Bucholz","year":"2018","journal-title":"Circulation."},{"issue":"17","key":"2022032516105108900_CIT0023","doi-asserted-by":"crossref","first-page":"e020800","DOI":"10.1161\/JAHA.121.020800","article-title":"Lower-intensity statins contributing to gaps in care for patients with primary severe hypercholesterolemia","volume":"10","author":"Eid","year":"2021","journal-title":"J Am Heart Assoc."},{"key":"2022032516105108900_CIT0024","author":"Eid"},{"issue":"22","key":"2022032516105108900_CIT0025","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: A Scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation."},{"issue":"6","key":"2022032516105108900_CIT0026","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"2022032516105108900_CIT0027","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacl.2020.04.011","article-title":"Genetic testing in dyslipidemia: a scientific statement from the National Lipid Association","volume":"14","author":"Brown","year":"2020","journal-title":"J Clin Lipidol."},{"issue":"25","key":"2022032516105108900_CIT0028","doi-asserted-by":"crossref","first-page":"e1046","DOI":"10.1161\/CIR.0000000000000624","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: executive summary","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"2022032516105108900_CIT0029","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jacl.2016.08.011","article-title":"Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions","volume":"10","author":"Ellis","year":"2016","journal-title":"J Clin Lipidol."},{"key":"2022032516105108900_CIT0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2017.03.021","article-title":"Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease","volume":"260","author":"Li","year":"2017","journal-title":"Atherosclerosis."},{"issue":"4","key":"2022032516105108900_CIT0031","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacl.2018.03.090","article-title":"Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease","volume":"12","author":"Chieng","year":"2018","journal-title":"J Clin Lipidol."},{"issue":"19","key":"2022032516105108900_CIT0032","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"2022032516105108900_CIT0033","doi-asserted-by":"crossref","first-page":"bvz015","DOI":"10.1210\/jendso\/bvz015","article-title":"Molecular characterization of familial hypercholesterolemia in a North American cohort","volume":"4","author":"Garg","year":"2020","journal-title":"J Endocr Soc"},{"issue":"2","key":"2022032516105108900_CIT0034","doi-asserted-by":"crossref","first-page":":1-16","DOI":"10.1515\/ijb-2016-0017","article-title":"Using relative statistics and approximate disease prevalence to compare screening tests","volume":"12","author":"Samuelson","year":"2016","journal-title":"Int J Biostat"},{"issue":"3","key":"2022032516105108900_CIT0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/radiol.14132832","article-title":"Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study","volume":"274","author":"Brem","year":"2015","journal-title":"Radiology."},{"issue":"2","key":"2022032516105108900_CIT0036","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jamacardio.2019.5173","article-title":"Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action","volume":"5","author":"Representatives of the Global Familial Hypercholesterolemia C","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022032516105108900_CIT0037","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.atherosclerosis.2018.08.051","article-title":"Overview of the current status of familial hypercholesterolaemia care in over 60 countries \u2013 the EAS familial hypercholesterolaemia studies collaboration (FHSC)","volume":"277","author":"EAS Familial Hypercholesterolaemia Studies Collaboration, EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators.","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"2022032516105108900_CIT0038","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2015.09.021","article-title":"Familial hypercholesterolaemia: a global call to arms","volume":"243","author":"Vallejo-Vaz","year":"2015","journal-title":"Atherosclerosis."},{"issue":"1","key":"2022032516105108900_CIT0039","doi-asserted-by":"crossref","first-page":"e003120","DOI":"10.1161\/CIRCGEN.120.003120","article-title":"Developing and optimizing innovative tools to address familial hypercholesterolemia underdiagnosis: identification methods, patient activation, and cascade testing for familial hypercholesterolemia","volume":"14","author":"Campbell-Salome","year":"2021","journal-title":"Circ Genom Precis Med."},{"issue":"6319","key":"2022032516105108900_CIT0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1126\/science.aaf7000","article-title":"Genetic identification of familial hypercholesterolemia within a single U.S. health care system","volume":"354","author":"Abul-Husn","year":"2016","journal-title":"Science"},{"issue":"22","key":"2022032516105108900_CIT0041","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"2022032516105108900_CIT0042","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jacl.2016.08.001","article-title":"Rapid identification of familial hypercholesterolemia from electronic health records: the SEARCH study","volume":"10","author":"Safarova","year":"2016","journal-title":"J Clin Lipidol."},{"issue":"2","key":"2022032516105108900_CIT0043","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MOL.0000000000000398","article-title":"The role of registries and genetic databases in familial hypercholesterolemia","volume":"28","author":"Kindt","year":"2017","journal-title":"Curr Opin Lipidol."},{"issue":"6","key":"2022032516105108900_CIT0044","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/hrt.2006.107391","article-title":"Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre","volume":"94","author":"Gray","year":"2008","journal-title":"Heart."},{"issue":"3","key":"2022032516105108900_CIT0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCGENETICS.116.001381","article-title":"Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: data from the CASCADE-FH registry","volume":"9","author":"deGoma","year":"2016","journal-title":"Circ Cardiovasc Genet."},{"issue":"22","key":"2022032516105108900_CIT0046","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation."},{"issue":"2","key":"2022032516105108900_CIT0047","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jacl.2019.01.009","article-title":"Comparative aspects of the care of familial hypercholesterolemia in the \u201cTen Countries Study\u201d","volume":"13","author":"Pang","year":"2019","journal-title":"J Clin Lipidol."},{"issue":"3","key":"2022032516105108900_CIT0048","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/heartjnl-2012-302917","article-title":"Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia","volume":"99","author":"Clarke","year":"2013","journal-title":"Heart."},{"issue":"1","key":"2022032516105108900_CIT0049","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2015.04.809","article-title":"Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology","volume":"241","author":"De Backer","year":"2015","journal-title":"Atherosclerosis."},{"key":"2022032516105108900_CIT0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41746-020-00349-5","article-title":"Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care","volume":"3","author":"Akyea","year":"2020","journal-title":"NPJ Digit Med."},{"key":"2022032516105108900_CIT0051","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41746-019-0101-5","article-title":"Finding missed cases of familial hypercholesterolemia in health systems using machine learning","volume":"2","author":"Banda","year":"2019","journal-title":"NPJ Digit Med."},{"issue":"11","key":"2022032516105108900_CIT0052","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/heartjnl-2015-308824","article-title":"A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice","volume":"102","author":"Troeung","year":"2016","journal-title":"Heart."},{"issue":"6","key":"2022032516105108900_CIT0053","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MOL.0000000000000714","article-title":"Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods","volume":"31","author":"Ibrahim","year":"2020","journal-title":"Curr Opin Lipidol."},{"key":"2022032516105108900_CIT0054","first-page":";S1933-2874(21)00244-0","article-title":"Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) \u2013 results of a US national survey","author":"Block","year":"2021","journal-title":"J Clin Lipidol"},{"issue":"14","key":"2022032516105108900_CIT0055","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jacc.2017.08.019","article-title":"Is ACS in young patients a \u201ccanary in the coal mine\u201d for familial hypercholesterolemia?","volume":"70","author":"Knowles","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"14","key":"2022032516105108900_CIT0056","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jacc.2017.08.009","article-title":"Genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome","volume":"70","author":"Amor-Salamanca","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"6","key":"2022032516105108900_CIT0057","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0004.2009.01356.x","article-title":"Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project","volume":"77","author":"Taylor","year":"2010","journal-title":"Clin Genet."},{"issue":"17","key":"2022032516105108900_CIT0058","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur Heart J."},{"issue":"3","key":"2022032516105108900_CIT0059","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/cge.13697","article-title":"The familial hypercholesterolaemia phenotype: monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes","volume":"97","author":"Mariano","year":"2020","journal-title":"Clin Genet."},{"issue":"12","key":"2022032516105108900_CIT0060","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"3","key":"2022032516105108900_CIT0061","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2217\/clp.14.19","article-title":"Underutilization of cascade screening for familial hypercholesterolemia","volume":"9","author":"Neal","year":"2014","journal-title":"Clin Lipidol"},{"key":"2022032516105108900_CIT0062","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","article-title":"Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia","volume":"201","author":"Chan","year":"2015","journal-title":"Int J Cardiol."},{"issue":"7","key":"2022032516105108900_CIT0063","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"31","key":"2022032516105108900_CIT0064","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.2174\/1381612824666181010150958","article-title":"Should we consider lipoprotein (a) in cardiovascular disease risk assessment in patients with familial hypercholesterolaemia?","volume":"24","author":"Anagnostis","year":"2018","journal-title":"Curr Pharm Des."},{"issue":"4","key":"2022032516105108900_CIT0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Emerging Risk Factors Collaboration","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"2022032516105108900_CIT0066","doi-asserted-by":"crossref","first-page":"103831","DOI":"10.1016\/j.ejmg.2019.103831","article-title":"Familial hypercholesterolemia: a complex genetic disease with variable phenotypes","volume":"63","author":"Di Taranto","year":"2020","journal-title":"Eur J Med Genet."},{"issue":"6","key":"2022032516105108900_CIT0067","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MOL.0000000000000713","article-title":"The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia","volume":"31","author":"Yeang","year":"2020","journal-title":"Curr Opin Lipidol."},{"issue":"5","key":"2022032516105108900_CIT0068","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacl.2019.06.011","article-title":"Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels","volume":"13","author":"Pavanello","year":"2019","journal-title":"J Clin Lipidol."},{"issue":"23","key":"2022032516105108900_CIT0069","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J."},{"issue":"11","key":"2022032516105108900_CIT0070","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1073\/pnas.86.11.4171","article-title":"Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis","volume":"86","author":"Utermann","year":"1989","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2022032516105108900_CIT0071","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.ejhg.5200152","article-title":"Concentrations of the atherogenic Lp(a) are elevated in FH","volume":"6","author":"Lingenhel","year":"1998","journal-title":"Eur J Hum Genet."},{"issue":"7","key":"2022032516105108900_CIT0072","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/heartjnl-2013-304902","article-title":"Lipoprotein(a): the underestimated cardiovascular risk factor","volume":"100","author":"Thompson","year":"2014","journal-title":"Heart."},{"issue":"25","key":"2022032516105108900_CIT0073","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation."},{"issue":"8","key":"2022032516105108900_CIT0074","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jamacardio.2021.1301","article-title":"Limited-variant screening vs comprehensive genetic testing for familial hypercholesterolemia diagnosis","volume":"6","author":"Sturm","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"5","key":"2022032516105108900_CIT0075","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jacl.2019.08.002","article-title":"The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs","volume":"13","author":"Virani","year":"2019","journal-title":"J Clin Lipidol."},{"issue":"2","key":"2022032516105108900_CIT0076","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCGENETICS.111.961144","article-title":"Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial","volume":"5","author":"Chasman","year":"2012","journal-title":"Circ Cardiovasc Genet."},{"issue":"3","key":"2022032516105108900_CIT0077","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on familial hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab873\/42103264\/dgab873.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/4\/1078\/42994551\/dgab873.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/4\/1078\/42994551\/dgab873.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T20:53:10Z","timestamp":1648241590000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/4\/1078\/6454310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":77,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,6]]},"published-print":{"date-parts":[[2022,3,24]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab873","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,12,6]]}}}